Laser Artery Disease Therapy: FDA approves next-gen laser atherectomy catheter
Spectranetics (Colorado Springs, CO) has received FDA 510(k) clearance for its Turbo-Power laser atherectomy catheter to treat in-stent restenosis (ISR).
Spectranetics (Colorado Springs, CO) has received FDA 510(k) clearance for its Turbo-Power laser atherectomy catheter to treat in-stent restenosis (ISR). The company notes that laser atherectomy is driving a new standard of care for treatment of coronary artery disease, with improved clinical outcomes. The tool uses vaporizing technology to maximize luminal gain-it debulks the lesion in a single step and offers remote automatic rotation for precise directional control.
About the Author
Barbara Gefvert
Editor-in-Chief, BioOptics World (2008-2020)
Barbara G. Gefvert has been a science and technology editor and writer since 1987, and served as editor in chief on multiple publications, including Sensors magazine for nearly a decade.
Sign up for Laser Focus World Newsletters
Get the latest news and updates.
Voice Your Opinion!
To join the conversation, and become an exclusive member of Laser Focus World, create an account today!
